2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Intranasal delivery of insulin for the restoration of memory signaling in Alzheimer disease

M. Bhargava, S. Bhargava, V. Bhargava (Kanpur, India)
Intrathecal Administration of Autologous Mesenchymal Stem Cells in Multiple System Atrophy – A Phase I/II Dose-Escalation Trial

W. Singer, A. Dietz, A. Zeller, T. Gehrking, J. Schmelzer, D. Sletten, J. Gehrking, E. Coon, P. Sandroni, E. Benarroch, R. Fealey, J. Matsumoto, J. Bower, J. Ahlskog, A. Hassan, A. McKeon, B. Klassen, P. Low (Rochester, MN, USA)
INTREPID Trial: A Prospective, Double blinded, Multi-center Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple-Source, Constant-Current Rechargeable System in Parkinson’s Disease

J. Vitek, R. Jain, P. Starr (Minneapolis, MN, USA)
Investigating the Association between Anxiety and Cognitive Impairment in Parkinson’s Disease: A Descriptive Study

A. Toft, J. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, D. Copland, N. Dissanayaka (Brisbane, Australia)
Investigating the Lipidomic Signature of Spinocerebellar Ataxia (SCA1) Using A Liquid-Microjunction Surface Sampling Probe

V. Vedam-Mai, E. Gill, M. Marks, R. Yost, T. Garrett (Gainesville, FL, USA)
Investigation of Non-Motor Symptoms Impacting Care Dependency in Individuals with Parkinson’s Disease

M. Bryant, A. Tan, J.-G. Hou, E. Protas (Houston, TX, USA)
Is cognitive decline similar among Parkinson’s disease motor sub-types? A prospective study examining changes over time in gait, balance and cognition

T. Herman, L. Arie, S. Shema-Shiratzky, N. Giladi, J. Hausdorff (Tel Aviv, Israel)
Is Hypertension and Certain Anti Hypertensive Agents Increase The Risk of Parkinson Disease?

R. Pinzon (Yogyakarta, Indonesia)
Is the cerebellum a good target for neuromodulation in movement disorders?

C. França, M. Teixeira, D. de Andrade, R. Galhardoni, V. Barbosa, V. Silva, G. Lepski, E. Barbosa, R. Cury (São Paulo, Brazil)
Is the GBA2 a new modifier for Gauchers’s disease and GBA1-related Parkinson’s disease?

E. Nakanishi, N. Uemura, H. Akiyama, M. Kinoshita, H. Yamakado, S. Takeda, Y. Hirabayashi, R. Takahashi (kyoto, Japan)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z